Risks in Antiemesis Using Dexamethasone
Authors:
- May M. AlhashimiMAMay M. Alhashimi
- Steven H. KrasnowSKSteven H. Krasnow
- Anita Johnston-EarlyAJAnita Johnston-Early
- Marc L. CitronMCMarc L. Citron
- 1 August 1984
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 101 (2) , 281
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Antiemetic Efficacy of High-Dose Dexamethasone in Induction Therapy in Acute Nonlymphocytic LeukemiaAnnals of Internal Medicine, 1984
- Intermittent high-dose cyclophosphamide with and without prednisolone. A study of the relationships between toxicity, response and survival in metastatic lung cancerCancer, 1982
- Causes of initial remission induction failure in acute myelogenous leukemiaBlood, 1982
- Controversies in the therapy of acute myelogenous leukemiaThe American Journal of Medicine, 1982
- Modulation of the toxicity and antitumour activity of alkylating drugs by steroidsBritish Journal of Cancer, 1982
- Nitrogen mustard and the steroid hormones in the treatment of inoperable bronchogenic carcinomaThe American Journal of Medicine, 1960